학술논문

Renal replacement therapy in patients with familial Mediterranean fever
Document Type
article
Source
Journal of Nephropathology, Vol 11, Iss 1, Pp e2-e2 (2022)
Subject
familial mediterranean fever
kidney transplantation
end-stage renal disease
hemodialysis
amyloidosis
Pathology
RB1-214
Internal medicine
RC31-1245
Other systems of medicine
RZ201-999
Language
English
ISSN
2251-8363
2251-8819
Abstract
One of the causes of end-stage renal disease (ESRD) in some countries is the renal involvement caused by the complications of the familial Mediterranean fever (FMF). Amyloidosis is of the most important complications of FMF that can lead to ESRD. We report our experiences of FMF patients with ESRD who received hemodialysis and kidney transplantation over the past 17 years. Of nine patients, four had amyloidosis, two had focal segmental glomerulosclerosis (FSGS), one had IgA nephropathy, and two did not undergo biopsy because their kidneys were atrophic. Of the nine patients, one died of amyloidosis. Seven patients had kidney transplantation and one patient is currently undergoing dialysis. Six patients were transplanted from a living donor and one from a cadaver. The ultrasound examination revealed that five patients had bilateral kidney atrophy, four patients had normal size kidney with amyloidosis. None of the seven patients who underwent renal transplantation had a history of rejection. Kidney transplantation and hemodialysis in patients with FMF is similar to those with other ESRD etiologies.